All talks & lectures

Invited lecture ·

Precision treatment strategies with machine learning in multiple sclerosis

An MS-PINPOINT progress talk linking routine MRI, health records and privacy-conscious machine learning.

Montreal Neurological Institute seminar · Montreal

Opening slide for “Precision treatment strategies with machine learning in multiple sclerosis” at Montreal Neurological Institute seminar
Opening slide from the original presentation
Delivered
Event
Montreal Neurological Institute seminar
Place
Montreal
Format
Invited lecture
Source deck
15 slides

From the slides

Deck notes

This seminar presented the MS-PINPOINT approach to precision treatment research in multiple sclerosis. It connected routine brain and spinal cord imaging with clinical records and privacy-conscious analysis across centres.

The question

How can routine-care data be used to estimate MS type, prognosis and treatment response while keeping data within participating centres?

Deck outline

  • The mismatch between clinical labels and underlying disease biology
  • Data-driven MRI subtypes of multiple sclerosis
  • Routine brain MRI, spinal cord imaging and electronic health records
  • Image segmentation designed for variable clinical scans
  • Foundation models and federated learning
  • A staged roadmap from imaging to multimodal treatment prediction

Take-away

The proposed route to precision treatment is incremental: make routine images measurable, combine them with clinical information, and support analysis across centres without centralising identifiable data.

Original deck

Slide by slide

Read the 15-slide presentation in order, or use the index to jump.

  1. Slide 01

    Precision Treatment Strategies with Machine Learning in Multiple Sclerosis (MS-PINPOINT)

    Slide 1: Precision Treatment Strategies with Machine Learning in Multiple Sclerosis (MS-PINPOINT)Open full-size slide

    Arman Eshaghi, MD, PhD

    Principal Research Fellow

    (Associate Professor)

    University College London

    United Kingdom

    18 July 2024 - Montreal

  2. Slide 03

    MS types do not match disease “biology”

    Slide 3: MS types do not match disease “biology”Open full-size slide

    Relapsing remitting MS

    Secondary progressive MS

    Primary progressive MS

    Speaker notes

    The effect size, expressed as mean difference in annual percentage cortical thickness change (MD-APC), is graphically displayed in different shades of blue for each of the Desikan-Killiany atlas25 regions presenting significant differences between groups after correction for multiple comparisons.

  3. Slide 05

    Routine care data

    Slide 5: Routine care dataOpen full-size slide

    Brain – lesion segmentation

    Spinal cord cross-section

    Electronic health records

  4. Slide 11

    Summary

    Slide 11: SummaryOpen full-size slide

    Routine care MRI analysis tools

    Data-derived subtypes and prognostic models

    Electronic health records

    Data stays at centers

  5. Slide 12

    Next steps

    Slide 12: Next stepsOpen full-size slide

    Imaging => now

    Clinical data => 2024

    Brain => early to mid 2025

    Spine => 2-3 years from today

    Multimodal => 2-3 years

  6. Slide 13

    Define MS type, prognosis, and treatment response

    Slide 13: Define MS type, prognosis, and treatment responseOpen full-size slide

    Personalise MS care and save costs

    Outcome and impact